David A. Siegel Bioventus Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Bioventus Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 13,432 shares of BVS stock, worth $142,647. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,432
Previous 91,532
85.33%
Holding current value
$142,647
Previous $526,000
69.58%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding BVS
# of Institutions
141Shares Held
45.8MCall Options Held
179KPut Options Held
124K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$138 Million44.65% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$73.7 Million33.68% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.35MShares$46.2 Million3.09% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$25.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.07MShares$22 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $655M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...